e-Therapeutics (LSE:ETX) Buyback Yield % : -25.58 (As of Sep. 21, 2024)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

e-Therapeutics's current buyback yield was -25.58%.

e-Therapeutics Buyback Yield % Historical Data

The historical data trend for e-Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Buyback Yield % Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Buyback Yield %

Get a 7-Day Free Trial

-0.08

-0.11

-16.13

-12.57

-14.25

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Buyback Yield %	Get a 7-Day Free Trial															-34.36	-0.02	-0.01	-28.48	-0.04

Competitive Comparison of e-Therapeutics's Buyback Yield %

For the Biotechnology subindustry, e-Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

e-Therapeutics's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, e-Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where e-Therapeutics's Buyback Yield % falls into.

e-Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

e-Therapeutics's Buyback Yield for the fiscal year that ended in Jan. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	13.437)	/	94.309758
	=	-14.25%

e-Therapeutics's annualized Buyback Yield for the quarter that ended in Jul. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0.022)	*	2	/	101.5344295
	=	-0.04%

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Jul. 2023) data.

e-Therapeutics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

ETXPF:USA

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021